Cargando…

The Role of Anti-Phosphatidylserine/Prothrombin Antibodies in Thrombotic Manifestations of Systemic Lupus Erythematosus Patients

Detalles Bibliográficos
Autores principales:	Tselios, Konstantinos, Sarantopoulos, Alexandros, Gkougkourellas, Ioannis, Boura, Panagiota
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671346/ https://www.ncbi.nlm.nih.gov/pubmed/23760175 http://dx.doi.org/10.3389/fneur.2013.00066

Ejemplares similares

Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report
por: Tselios, Konstantinos, et al.
Publicado: (2011)

Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk
por: Egri, Natalia, et al.
Publicado: (2021)

Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA Cohort
por: Mullen, Michael T., et al.
Publicado: (2012)

Systemic Sclerosis and Silicone Breast Implant: A Case Report and Review of the Literature
por: Psarras, Antonios, et al.
Publicado: (2014)

Chronic Brucellosis Patients Retain Low Frequency of CD4+ T-Lymphocytes Expressing CD25 and CD28 after Escherichia coli LPS Stimulation of PHA-Cultured PBMCs
por: Skendros, Panagiotis, et al.
Publicado: (2008)

Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study
por: Sciascia, Savino, et al.
Publicado: (2021)

Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes
por: Žigon, Polona, et al.
Publicado: (2015)

Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss
por: Pleguezuelo, Daniel E., et al.
Publicado: (2021)

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study
por: Sciascia, Savino, et al.
Publicado: (2019)

Anti-β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies exert similar pro-thrombotic effects in peripheral blood monocytes and endothelial cells
por: Cifù, A., et al.
Publicado: (2019)

Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies
por: Radin, Massimo, et al.
Publicado: (2020)

Anti-Phosphatidylethanolamine and Anti-Phosphatidylserine Antibodies—Association with Renal Involvement, Atherosclerosis, Cardiovascular Manifestations, Raynaud Phenomenon and Disease Activity in Polish Patients with Systemic Lupus Erythematosus
por: Fischer, Katarzyna, et al.
Publicado: (2022)

Establishment of a rat model of thrombosis induced by intravenous injection of anti-phosphatidylserine–prothrombin complex antibody
por: Yamada, Mai, et al.
Publicado: (2017)

The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6 months of observation
por: Fabris, Martina, et al.
Publicado: (2014)

Phosphatidylserine-dependent anti-prothrombin antibodies (aPS/PT) in infliximab-treated patients with inflammatory bowel diseases
por: Malíčková, Karin, et al.
Publicado: (2012)

Low frequency of phosphatidylserine/prothrombin complex antibodies in a cohort of patients with anticardiolipin antibodies and recent thrombosis
por: Locht, H
Publicado: (2003)

Anti-Phosphatidylserine, Anti-Prothrombin, and Anti-Annexin V Autoantibodies in Antiphospholipid Syndrome: A Real-Life Study
por: Roselli, Daniele, et al.
Publicado: (2023)

Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies
por: Tselios, Konstantinos, et al.
Publicado: (2016)

Gradual Glucocorticosteroid Withdrawal Is Safe in Clinically Quiescent Systemic Lupus Erythematosus
por: Tselios, Konstantinos, et al.
Publicado: (2021)

Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE
por: Elbagir, Sahwa, et al.
Publicado: (2022)

Quiescent Systemic Lupus Erythematosus Manifesting with Thrombotic Thrombocytopenic Purpura and Acute Renal Failure: A Case Report and Short Literature Review
por: Melissaropoulos, Konstantinos, et al.
Publicado: (2021)

Sense of smell, anti-ribosomal p antibodies and neuropsychiatric manifestations in childhood systemic lupus erythematosus
por: Peres, Fernando A, et al.
Publicado: (2014)

Paratope diversity of anti-prothrombin antibodies
por: Cucnik, S, et al.
Publicado: (2003)

Association of Antiphospholipid Antibodies with Clinical Manifestations in Children with Systemic Lupus Erythematosus
por: Petrovic, Gordana, et al.
Publicado: (2023)

Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies
por: Conti, Fabrizio, et al.
Publicado: (2004)

Lupus nephropathy as the initial manifestation of systemic lupus erythematosus.
por: Lynn, R. I., et al.
Publicado: (1980)

LUPUS PANNICULITIS AS AN INITIAL MANIFESTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS
por: Patel, Raksha M, et al.
Publicado: (2010)

Cutaneous Manifestations of “Lupus”: Systemic Lupus Erythematosus and Beyond
por: Cooper, Elizabeth E., et al.
Publicado: (2021)

Cutaneous Manifestations of Systemic Lupus Erythematosus
por: Uva, Luís, et al.
Publicado: (2012)

Respiratory Manifestations in Systemic Lupus Erythematosus
por: Di Bartolomeo, Salvatore, et al.
Publicado: (2021)

Thrombotic thrombocytopenic purpura treated with rituximab in systemic lupus erythematosus
por: Karimifar, Mansoor
Publicado: (2012)

Thrombotic thrombocytopenic purpura as the first presentation in systemic lupus erythematosus
por: Bamidele, Opeyemi Folorunsho, et al.
Publicado: (2018)

Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays
por: Tsutsumi, Akito, et al.
Publicado: (2006)

Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations
por: Becker, Yann, et al.
Publicado: (2019)

Anti‐β2‐glycoprotein I and anti‐prothrombin antibodies cause lupus anticoagulant through different mechanisms of action
por: Noordermeer, Tessa, et al.
Publicado: (2021)

Anti-IL-10 antibody in systemic lupus erythematosus
por: Uchida, Marina, et al.
Publicado: (2019)

Systemic Lupus Erythematosus and COVID-19
por: Pappa, Maria, et al.
Publicado: (2023)

Risk factors for thrombotic events in Korean patients with systemic lupus erythematosus
por: Park, Dong-Jin, et al.
Publicado: (2021)

Postpartum Pulmonary-Renal Syndrome with Thrombotic Microangiopathy in Systemic Lupus Erythematosus
por: Jha, Vijoy Kumar, et al.
Publicado: (2023)

Cricoarytenoiditis as an Initial Manifestation of Systemic Lupus Erythematosus
por: Hougardy, Jean-Michel, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vpbj7bcngsalfd03vn1e5jeji9